Nasal swine flu vaccine recalled over potency

Dec 22, 2009

(AP) -- Drugmaker Medimmune is recalling nearly 5 million doses of swine flu vaccine because the nasal spray appears to lose strength over time.

The Food and Drug Administration said Tuesday that the vaccine is safe and patients who received the product should be protected from the H1N1 virus.

The FDA says the vast majority of the doses have already been distributed and used. Agency officials say the vaccine met potency specifications when it was distributed in October and November.

Last week, another vaccine maker recalled shots for children because tests indicated those doses lost some strength.

Explore further: New system targets germs in donated blood plasma

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Kids' Swine flu shots recalled; not strong enough

Dec 15, 2009

(AP) -- Hundreds of thousands of swine flu shots for children have been recalled because tests indicate the vaccine doses lost some strength, government health officials said Tuesday.

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

Recommended for you

New system targets germs in donated blood plasma

16 minutes ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.